Quibin

Quibim is a healthtech company focused on quantitative imaging biomarkers, radiomics, and AI-powered medical imaging software for precision medicine. The company provides a cloud-based platform, QP-Insights, for harmonizing, storing, and analyzing imaging and related clinical or multi-omics data, and it markets software products such as QP-Prostate, QP-Brain, and QP-Liver for healthcare providers. Quibim also partners with biopharma companies to support drug development, patient stratification, response prediction, and safety monitoring using MRI, CT, and PET data. Its business spans both provider-facing software as a medical device and life-sciences collaborations aimed at generating predictive and prognostic imaging biomarkers. The company has obtained regulatory clearances including CE/UKCA marking and U.S. FDA 510(k) clearance for aspects of QP-Prostate. Quibim is headquartered in Spain and has expanded internationally with offices in the United States and United Kingdom.